MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
473.20
+0.08
+0.02%
Closed 16:49 02/10 EST
OPEN
475.01
PREV CLOSE
473.12
HIGH
475.69
LOW
468.62
VOLUME
234.02K
TURNOVER
0
52 WEEK HIGH
519.99
52 WEEK LOW
266.98
MARKET CAP
20.37B
P/E (TTM)
17.92
1D
5D
1M
3M
1Y
5Y
1D
United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares
Reuters · 12h ago
United Therapeutics Nears Key Data Milestone With Completed TETON-1 IPF Trial
TipRanks · 17h ago
Weekly Report: what happened at UTHR last week (0202-0206)?
Weekly Report · 2d ago
Assessing United Therapeutics (UTHR) Valuation After Positive MiroliverELAP Phase 1 Safety And Survival Data
Simply Wall St · 5d ago
United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares
Reuters · 5d ago
United Therapeutics: In Progress -- New Organs For Old At Scale
Seeking Alpha · 6d ago
Noteworthy Wednesday Option Activity: FHN, UTHR, SLAB
NASDAQ · 6d ago
United Therapeutics Director Jan Malcolm Reports Sale of Common Shares
Reuters · 02/03 21:32
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.